Gain Unrivalled Insights Into GBM-Specific Clinical Trial Rationale to Keep Ahead of the Curve
Time: 2:00 pm
day: Conference Day 1
Details:
- Overview of the updated response criteria for glioblastomas and IDH-mutated gliomas: RANO 2.0
- Sharing therapeutic modality-specific advice on clinical trial design
- Analyzing novel endpoints for glioma trials
